Patient Identification

Mr. Ahmed Al Hassan is a Somali-born guy of 67 years. He resides in Wisconsin and defines him as a smoker who rarely consumes alcohol. He leads a hockey team in the area and likes going out for burritos and hamburgers after games. His medical records from the community hospital indicate Hassan does not regularly check his BP readings, and the most recent findings reveal a blood pressure of around 160/102. The body mass index results indicate a robust man, but he shows anxiety because his blood pressure levels are higher than earlier measurements. The data is problematic regarding his BP and cholesterol and excessive salt consumption in his food. He significantly risks acquiring hypertension (HTN) and other cardiac illnesses if his condition is not managed. As a result, in this analysis, I will discuss a recommended healthcare plan target pertinent to Mr. Hassan’s health concern. Using Mr. Hassan as a model, the paper will concentrate on hypertension prevention and management.

Several researchers have discussed the issues regarding hypertension and methods to treat and avoid its hazards. For example, Chung et al. (2019) are among some writers I believe provide solid information on it. The authors examine the varied criteria for identifying, preventing, and treating the condition in adulthood in their study. Furthermore, the research by Etched et al. (2020) can assist in understanding how discrepancies in the management of hypertension persist among minority populations such as Somalis. The treatment regimen will help outline Mr. Hassan’s condition and how a physician might treat his condition to attain the Healthy People 2030 goals.

My project’s focus will include nurse education about managing an HTN individual. In my profession as a Registered nurse, I have seen a substantial percentage of readmissions due to nursing staff’ carelessness and inadequate actions with patient populations, such as in this particular instance, where the nurse failed to give the individual the appropriate beta-blocker dosage and failed to teach Mr. Hassan about HTN self-management as well as checking and regulation.  

NURS FPX 4900 Assessment 1 Assessing the Problem: Leadership Collaboration Communication Change Management and Policy Considerations

Evidence-Based Approach 

The primary objective of HTN management is to attain and sustain a targeted level of BP and manage hypertensive adults over the age of 60). Lifestyle modifications, including nutritional therapies (reducing salt intake, increasing electrolytes, eliminating alcohol, and multifactorial dietary regulation), weight reduction, quitting smoking, regular exercise, and managing stress, should be the preliminary stage in HTN management. A comprehensive strategy to intervention may help lower blood pressure in senior patients with HTN. Multidisciplinary strategies to HTN management that use collaborative management amongst doctors, nursing staff, clinicians, nutritionists, and physical therapists have significant benefits over typical general practitioner therapy—broadening the reach of procedure for health healthcare staff, chemists, and allied health professionals’ evaluation, prescribing, and providing a systematic therapy as a component of coherent partnerships. It creates an opportunity to confront such shortfalls in achieving BP goals. Further study on intervention strategies that include numerous healthcare professionals as representatives of a treatment team, and also intervention strategies by nutrition experts as well as physical therapists are required to ascertain the highest quality approaches for collaborative efforts as well as the implementation of broadening clinical expertise, such as individualized prescribed medication by prescribers and nursing staff, where accessible. 

American Heart Association (AHA) hypertensive guidelines include almost every aspect of hypertensive assessment, examination, screening, related complications, medications, and quasi-treatment. In all situations where reliable blood pressure measurements are desired, considerable and suitable emphasis has been paid to the processes necessary for reliable BP measurement. Many “failures” in blood pressure monitoring raise concerns, resulting in over-diagnosis of HTN and, in patients already on pharmaceutical intervention, underestimating the extent of blood pressure decrease. The vast percentage of people with stage 1 HTN does not require immediate pharmacological therapy. A considerable amount of recommendations in the guidelines are innovative.

Whenever stage 1 HTN and high-risk patient characteristics such as age 65 years or above, metabolic syndrome, renal failure, and recognized heart disease are nonexistent, the ultimate cardio